* Molecular Cardiobiology Program and the Department of Pharmacology, Catalytically active endothelial nitric oxide
synthase (eNOS) is located on the Golgi complex and
in the caveolae of endothelial cells (EC). Mislocalization of eNOS caused by mutation of the N-myristoylation or cysteine palmitoylation sites impairs production of stimulated nitric oxide (NO), suggesting that intracellular targeting is critical for optimal NO production.
To investigate the molecular determinants of eNOS
targeting in EC, we constructed eNOS-green fluorescent protein (GFP) chimeras to study its localization in
living and fixed cells. The full-length eNOS-GFP fusion
colocalized with a Golgi marker, mannosidase II, and
retained catalytic activity compared to wild-type (WT)
eNOS, suggesting that the GFP tag does not interfere
with eNOS localization or function. Experiments with
different size amino-terminal fusion partners coupled
to GFP demonstrated that the first 35 amino acids of
eNOS are sufficient to target GFP into the Golgi region
of NIH 3T3 cells. Additionally, the unique (Gly-Leu)5
repeat located between the palmitoylation sites (Cys-15
and -26) of eNOS is necessary for its palmitoylation and
thus localization, but not for N-myristoylation, membrane association, and NOS activity. The palmitoylation-deficient mutants displayed a more diffuse fluorescence pattern than did WT eNOS-GFP, but still were
associated with intracellular membranes. Biochemical studies also showed that the palmitoylation-deficient
mutants are associated with membranes as tightly as
WT eNOS. Mutation of the N-myristoylation site Gly-2
(abolishing both N-myristoylation and palmitoylation)
caused the GFP fusion protein to distribute throughout
the cell as GFP alone, consistent with its primarily cytosolic nature in biochemical studies. Therefore, eNOS
targets into the Golgi region of NIH 3T3 cells via the
first 35 amino acids, including N-myristoylation and
palmitoylation sites, and its overall membrane association requires N-myristoylation but not cysteine palmitoylation. These results suggest a novel role for fatty
acylation in the specific compartmentalization of eNOS and most likely, for other dually acylated proteins, to
the Golgi complex.
Targeting of receptors to the plasma membrane is a
necessary event for receptor-dependent signal
transduction. Integral membrane proteins destined
for the plasma membrane are processed via the classical
ER-Golgi pathway and are inserted into the plasma membrane via hydrophobic stretches of amino acids encompassing transmembrane domains. Other posttranslational
modifications, such as N-glycosylation and cysteine palmitoylation, impart features to the membrane protein that
can determine extracellular versus intracellular domains, and can influence protein stability and turnover. In contrast, the mechanisms by which fatty acylated, peripheral
membrane proteins target to and reside in intracellular
membranes are less well understood.
The To elucidate the molecular signals and the role(s) of lipid
modifications in targeting of eNOS, we fused the green
fluorescent protein (GFP) isolated from the jellyfish Aequorea victoria to the carboxyl terminus of eNOS, and we
assessed the regions of NOS necessary for trafficking and
overall membrane association. Our results demonstrate
that the first 35 amino acids, including the N-myristoylation and palmitoylation sites of eNOS, are responsible for
its Golgi localization and membrane association. These results provide a novel role for fatty acylation in the specific
compartmentalization of eNOS and most likely other dually acylated proteins to the Golgi complex, and suggest
that N-myristoylation and cysteine palmitoylation, in addition to imparting hydrophobic character to proteins, are
important constituents of a Golgi targeting signal for certain peripheral membrane proteins.
Generation of eNOS-GFP Fusions
Standard molecular cloning techniques were used to manipulate DNA.
The constructs discussed in this paper are summarized in Fig. 2. WT and
C15/26S mutant (in which cysteine 15 and/or 26 have been mutated to
serine) eNOS cDNAs were constructed and subcloned into the mammalian expression vector pcDNA3 (Liu et al., 1995
Cell Transfection and Fluorescence Microscopy
NIH 3T3 cells were grown in DME containing penicillin (100 IU/ml), streptomycin (100 mg/ml), and 10% (vol/vol) FBS (complete DME), and were
transfected for 6 h with indicated plasmids according to the standard calcium phosphate precipitation method.
The localization of eNOS and eNOS-GFP fusions in living and fixed
cells was examined by fluorescence microscopy between 48 and 60 h after
transfection. In some experiments, eNOS was colocalized with the resident Golgi protein mannosidase II (Man II). Transfected NIH 3T3 cells
were fixed in 2% paraformaldehyde in PBS for 10 min at room temperature and subsequently permeabilized with 0.1% (vol/vol) Triton X-100 in
PBS/0.1% (wt/vol) BSA for 5 min. Cells were incubated with Man II polyclonal antibody for 1 h, followed by washing and incubation for 45 min
with Texas red-labeled second antibodies (Jackson Immunoresearch Laboratories, West Grove, PA). The specificity of the Man II and eNOS antibodies has been demonstrated previously (Moreman and Touster, 1986 Metabolic Labeling and Immunoprecipitation
Transiently transfected NIH 3T3 cells (on T-75 flasks) were preincubated
for 30 min with cerulenin (2 µg/ml), an inhibitor of fatty acid synthetase,
in serum-free DME containing BSA (10 mg/ml, fatty acid free). Cells were
then labeled with 300 µCi/ml of [3H]myristic acid or [3H]palmitic acid (45-
50 Ci/mmol; New England Nuclear, Boston, MA) for 4 h in the same medium. The 3H-fatty acids were dried under N2 and redissolved in DMSO
so that the final concentration of DMSO in the labeling medium was 0.1%.
For immunoprecipitation, cells were solubilized by incubation in 1 ml
of the modified RIPA buffer for 30 min at 4°C. Lysates were centrifuged
at 10,000 g for 5 min to remove insoluble material, and 2 µg of GFP polyclonal antibody (Clontech Laboratories, Palo Alto, CA) was added and
incubated for 2 h at 4°C. 15 µl of protein A-Sepharose (Pharmacia Fine
Chemicals, Piscataway, NJ) suspension (1:1 in RIPA buffer) was added
and incubated for 1 h at 4°C. The beads were pelleted, washed three times
with 1 ml RIPA buffer, and then boiled in SDS-PAGE sample buffer for 5 min. Proteins were separated by SDS-PAGE visualized by Coomassie
blue staining followed by fluorographic analysis as described previously
(Liu et al., 1995 Cell Fractionation and NOS Activity Assays
For cell fractionation studies, transfected cells were rinsed with ice-cold
PBS, scraped into the same buffer, and centrifuged at 600 g for 5 min. Cell
pellets were resuspended in 1 ml of homogenization buffer (50 mM Tris-HCl/0.1 mM EDTA/0.1 mM EGTA/2 µM leupeptin/1 µM pepstatin A/1 µM
aprotinin/1 mM PMSF/10 mM NaF/1 mM Na3VO4, pH 7.5) and sonicated
at 4°C (15 s, three times, at 50 W of power). Lysates were centrifuged at
100,000 g for 90 min at 4°C to separate the membrane and cytosolic fractions. The relative amount of eNOS-GFP was analyzed by Western blotting with GFP antibodies.
NOS activities of samples were assayed by determining the conversion
of [3H]l-arginine into [3H]l-citrulline, the stoichiometric reaction product
generated by NOS. In brief, lysates (50-µg proteins) were incubated (total volume = 0.1 ml) in a 50 mM Tris-HCl/0.1 mM EDTA/0.1 mM EGTA
buffer, pH 7.5, containing 1 mM NADPH, 3 µM tetrahydrobiopterin, 100 nM calmodulin, 2.5 mM CaCl2, 10 µM l-arginine, and [3H]l-arginine (0.1 µCi, sp act = 55 Ci/mmol) for 20 min at 37°C. After the incubation period,
the reaction was quenched by the addition of 1 ml of 20 mM Hepes stop
buffer, pH 5.5 (containing 2 mM EDTA and 2 mM EGTA). The reaction
mix was then passed over a 1-ml column containing Dowex AG 50WX-8
(Na+ form) resin (preequilibrated in stop buffer), washed with 1 ml of water, and collected directly into a 20-ml liquid scintillation vial containing
scintillation cocktail as previously described (Bredt and Snyder, 1990 Fusion of eNOS with GFP Does Not Interfere with the
Localization and Catalytic Activity of eNOS
We initially asked whether GFP could be used as a reporter protein to study eNOS localization in living cells.
To this end, NIH 3T3 cells were transiently transfected with
expression plasmids for GFP alone or with full-length eNOS
cloned in frame with GFP (eNOS-GFP), and subcellular
localization was determined by fluorescence microscopy.
Cells that were transfected with a construct encoding GFP
alone displayed diffuse fluorescence throughout the cells (Fig. 1 A, left), occasionally concentrating in the nucleus,
which is consistent with previous reports demonstrating
that GFP is synthesized as a cytosolic protein and randomly distributes throughout the cytosol (Prasher et al., 1992
To examine if the addition of GFP to the carboxyl terminus of eNOS interfered with the catalytic properties of
the enzyme, we performed NOS activity assays in lysates
from transfected cells. NOS-specific activities (quantified
by the conversion of [3H]l-arginine to [3H]l-citrulline)
were 24 ± 3 and 26 ± 4 pmol citrulline/min per mg protein
for WT eNOS and WT eNOS-GFP, respectively (n = 2 in duplicate). All NOS activity was completely abrogated by
incubation of lysates with the NOS inhibitor nitro-l-arginine methyl ester (1 mM, data not shown). Therefore, the
fusion of eNOS with GFP did not interfere with the dimerization of eNOS or NADPH, calcium, and tetrahydrabiopterin-dependent activation of NOS.
The First 35 Amino Acids of eNOS Are Sufficient to
Target GFP into the Golgi Region
The above observations support the conclusion that the
fusion partner rather than GFP determines the subcellular
localization of the hybrid protein. Therefore, GFP can be
used as a tag to track the targeting signal of eNOS in living
cells. To pinpoint the amino acid sequences of eNOS responsible for its localization, constructs encoding varying
lengths of the amino terminal regions of eNOS fused to
GFP were designed (illustrated in Fig. 2 A). Fig. 3 A shows
that fusions of amino acids 1-508, 1-131, or 1-73 of eNOS
to GFP are capable of targeting the eNOS-GFP fusion
protein into the perinuclear region of living, transfected
NIH 3T3 cells; the same pattern exhibited by WT eNOS.
This is in contrast to the diffuse fluorescence pattern seen
with eNOS (1-35) GFP. The diffuse distribution of this
construct suggested that either amino acids 36-73 were important for targeting or that the relatively large GFP protein (238 amino acids) may be interfering with the ability
of the first 35 amino acids to act as a targeting signal. Interestingly, in biosynthetic labeling studies, eNOS (1-35) GFP was N-myristoylated, but not palmitoylated, and was enriched in high speed membrane fractions, whereas G2A
eNOS (1-73) GFP (Fig. 3 B) and GFP alone (data not
shown) were cytosolic in lysates prepared from transfected
NIH 3T3 cells. To examine the possibility that the spacing
of amino acids between 1-35 and GFP could account for
lack of targeting of the chimeric protein, we created two additional constructs, eNOS (1-35/74-131) GFP and eNOS
(1-35) G10-GFP. We reasoned that amino acids 74-131
most likely do not contribute significantly to its perinuclear targeting, since eNOS (1-73) GFP and eNOS (1-131)
GFP display identical intracellular localization patterns compared to WT eNOS (see Fig. 3 A). As shown in Fig. 4 A,
eNOS (1-35/74-131) GFP was localized in the perinuclear region of living cells and colocalized with Man II in fixed
cells. Using a heterologous spacer of 10 glycines to separate eNOS from the GFP (eNOS [1-35]G10-GFP) resulted
in identical localization into the Golgi region of NIH 3T3
cells (Fig. 4 B). Therefore, the first 35 amino acids of
eNOS are responsible for Golgi targeting.
N-Myristoylation and Cysteine Palmitoylation Are
Necessary for eNOS Golgi Targeting
Next, we examined if eNOS(1-35/74-131) GFP and eNOS
(1-35)G10-GFP were still N-myristoylated and palmitoylated,
since the first 35 amino acid sequence includes the N-myristoylation site (Gly-2) and palmitoylation sites (Cys-15 and -26).
When cells transfected with WT eNOS-GFP, eNOS(1-35/
74-131) GFP, eNOS (1-35)G10-GFP, or GFP alone were
metabolically labeled with the appropriate 3H-fatty acid,
the full-length and truncated eNOS-GFP fusion proteins were N-myristoylated and palmitoylated, but GFP alone
was not (Fig. 4 C). This is in contrast to the eNOS (1-35)
GFP that was N-myristoylated but not palmitoylated (Fig.
3 B), suggesting that the spacing between the eNOS and
GFP was critical for recognition by palmitoyl transferase.
To examine the importance of fatty acylation to targeting, G2A eNOS-GFP (neither N-myristoylated nor palmitoylated) and C15/26S eNOS-GFP (N-myristoylated but
not palmitoylated) were constructed and transfected into
NIH 3T3 cells. As shown in Fig. 5 A, acylation-defective G2A eNOS-GFP distributed throughout the cells as did
GFP alone, while palmitoylation-deficient mutant C15/26S
eNOS-GFP (Fig. 5 B) was still retained in the perinuclear
region, but in a more diffuse pattern compared to WT
eNOS-GFP (Fig. 1). The G2A eNOS construct did not
colocalize with Man II (Sessa et al., 1995
The (Gly-Leu)5 Repeat between the eNOS
Palmitoylation Sites Is Important for Its
Palmitoylation and Localization but Not for Its Overall
Membrane Association
The unique pentameric dipeptide repeat (Gly-Leu)5 located between the C15 and C26 palmitoylation sites of
eNOS has been speculated to be important for NOS acylation and intracellular targeting (Liu et al., 1995
We previously showed that mutation of the palmitoylation sites of eNOS does not affect its overall membrane association with respect to removal of the enzyme from membranes by high salt or high pH and its relative distribution
between Triton X-114 detergent and aqueous phases, suggesting that hydrophobic factor(s), besides palmitoylation,
most likely contribute to its membrane association. To examine the importance of the glycine-leucine repeat in the overall membrane association, NIH 3T3 cells transfected
with WT, L2S, or C/L2S eNOS-GFP were fractionated
into high speed membranes and cytosolic fractions, and
eNOS-GFP fusion proteins were analyzed by Western blotting. As shown in Fig. 8, the palmitoylation-deficient mutants, L2S eNOS-GFP and C/L2S eNOS-GFP, were still
associated with the high speed cellular membrane as tightly
as WT or C15/26S eNOS-GFP, in agreement with the GFP
fluorescence data. NOS activity in cell lysates demonstrated
that these two mutants were catalytically active (31 and 27 pmol citruline/min per mg protein for L2S eNOS-GFP and L/C2S eNOS-GFP, respectively). Therefore, the (Gly-Leu)5 repeat is not important for overall membrane association of eNOS, but most likely contributes to its recognition by cysteine palmitoyl transferases.
The subcellular compartmentalization of eNOS is critical
for optimal production of NO. Mutations that disrupt
N-myristoylation or cysteine palmitoylation interfere with
proper intracellular targeting and attenuate the stimulated
production of NO from intact cells without affecting the
catalytic properties of the enzyme in vitro (Sessa et al.,
1995 Previously, we and others demonstrated that eNOS resides primarily on the Golgi and in plasmalemmal caveolae
of EC. As seen with the dually acylated Src family members Hck, Fyn, and Fgr, mutation of the palmitoylation
sites attenuates protein targeting to caveolae (Shenoy-Scaria et al., 1994 The use of eNOS-GFP chimeras for the dissection of
the eNOS localization signal reveals that the intracellular
fate of eNOS is inherent in its first 35 amino acids when an
appropriate protein spacer is included between eNOS and
GFP. Both eNOS (1-35/74-131) GFP and eNOS (1-35) G10-GFP constructs are N-myristoylated, palmitoylated, and
properly targeted to the Golgi region of 3T3 cells. Interestingly, the first 35 amino acids of eNOS fused to GFP or
mutation of leucine residues flanking the palmitoylation
sites in the context of full-length eNOS attenuate cysteine
palmitoylation, but do not influence N-myristoylation or
the relative membrane association of the fusion protein,
clearly demonstrating that intracellular membrane targeting and biochemical membrane association are not synonymous terms. These data also suggest that N-myristoylation of the eNOS fusion in the context of the first 35 amino
acids is sufficient for stable membrane association, but not
for proper targeting. It is questionable whether N-myristoylation per se is sufficient for membrane association of a
myristoylated protein. Based on energetic measurements
modeling the interaction of N-myristoyl peptides with phospholipid vesicles, the calculated Gibbs free energy cannot
suffice for stable membrane association to occur (Peitzsch
and McLaughlin, 1993 Lipid modifications via N-myristoylation and cysteine
palmitoylation are critical features for the intracellular localization and membrane association of G protein The pentameric glycine-leucine repeat embedded in the
novel dual acylation motif found in eNOS (M1GXXXS . . . C15(GL)5C26), unlike those found in G proteins or Src family members (Mumby et al., 1994 Overall, we have shown a potential biosynthetic pathway for the targeting of a representative, dually acylated,
peripheral membrane protein, eNOS. Identification of the
sequences required for Golgi targeting of eNOS will permit the expression of other transgenes into the Golgi region of heterologous cell systems. More importantly, visualization of the eNOS-GFP in living cells will allow us to
examine hormone- and shear stress-regulated movement of eNOS between Golgi and caveolae in real time.
Received for publication 30 January 1997 and in revised form 22 April 1997.
We thank Drs. Kelley Moreman and Jennifer Pollock for mannosidase II
and eNOS antibodies, respectively.
This work is supported by grants from the National Institutes of Health
(HL51948 and HL50974, to W.C. Sessa; F32-HL09224, to J. Liu; and
EY08362, to T.E. Hughes), and a grant-in-aid from the American Heart
Association. W.C. Sessa is an Established Investigator of the American
Heart Association.
Department
of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut 06536-0812
Abstract
subunit of heterotrimeric G proteins and endothelial nitric oxide synthase (eNOS)1 are peripheral membrane proteins that target to specific intracellular domains
(including the Golgi complex and plasmalemmal caveolae) requiring cotranslational N-myristoylation and posttranslational cysteine palmitoylation (Sessa et al., 1995
; García-Cardeña et al., 1996a
; Wedegaertner et al., 1995
). For dually
acylated G proteins and eNOS, mutation of the myristic acid
acceptor site glycine-2 inhibits both N-myristoylation and
cysteine palmitoylation and converts the membrane-associated form of the proteins to a cytosolic form (Sessa et al.,
1993
; Liu et al., 1995
), suggesting that fatty acylation reactions are essential for membrane association and targeting.
Mutation of the palmitoylation sites (cysteines 3 or 5 for G
proteins or cysteines 15 and 26 for eNOS) preserves N-myristoylation but has variable effects on overall protein hydrophobicity and membrane targeting (Wedegaertner et al., 1995
; Liu et al., 1995
; Robinson and Michel, 1995
).
For eNOS, inhibition of dual acylation prevents Golgi targeting and mutation of the palmitoylation sites attenuates
caveolae targeting (Sessa et al., 1995
; García-Cardeña et
al., 1996a
). In both circumstances, the mislocalization of eNOS has functional consequences; the stimulated production of nitric oxide (NO) is markedly reduced even
though the purified mutant enzymes are catalytically identical to wild-type (WT) eNOS (Sessa et al., 1995
; Liu et al.,
1996
). In confirmation of these cellular studies, mislocalization of eNOS in CA1 region stratum radiatum neurons, via
expression of a dominant-negative eNOS or inhibition of
N-myristoylation, blocks long-term potentiation (Kantor
et al., 1996
). These data suggest that fatty acylation and
Golgi targeting are critical for NOS translocation into specific post-Golgi domains and that localization is required
for efficient NO production.
Materials and Methods
). The cloned GFP cDNAs
(Marshall et al., 1995
) originally from TU-65 (Chalfie et al., 1994
) and
eNOS (WT, C15/26S, G2A) in pcDNA3 were used as templates for PCR.
To generate eNOS-GFP pcDNA3 plasmids, the first methionine of GFP
was changed into alanine to create an NheI site, and an NheI site was
added to the 3
end of eNOS coding sequence through PCR amplification.
The L2S eNOS mutant (the five leucine residues between Cys-15 and -26 mutated into serines) and C/L2S eNOS (the five leucine residues and Cys-15 and -26 mutated into serines) were generated through PCR. The sequences of the ligated PCR fragments cloned into pCDNA3 were verified
by DNA sequencing. The fusion proteins were of the predicted molecular
masses, as confirmed by Western blotting using GFP or eNOS antisera.
Fig. 2.
Schematic illustration of eNOS-GFP fusions (A) and
mutants (B). M, myristate; P, palmitate.
[View Larger Version of this Image (22K GIF file)]
;
Sessa et al., 1995
). After washing, slides were mounted with Slowfade
(Molecular Probes, Eugene, OR) and the cells were observed with a fluorescence microscope.
). Immunoprecipitation experiments demonstrated that 2 µg
of GFP polyclonal antibody quantitatively and specifically precipitated
eNOS-GFP fusion proteins from transfected cells (T-75 flask) using the
above conditions (data not shown).
). The
amount of [3H]l-citrulline generated per milligram of protein was used as an index of NOS activity.
Results
;
Marshall et al., 1995
) and, in COS cells, can also accumulate in nuclei (Moriyoshi et al., 1996
). When GFP was fused
to the carboxyl terminus of eNOS, an intense, perinuclear
fluorescent pattern was visualized (Fig. 1 A, right) similar
to that of native eNOS in aortic endothelial cells (EC)
(Sessa et al., 1995
). In addition, there was faint fluorescence diffusely distributed throughout the cell, most likely caused by a cytosolic form of eNOS-GFP or eNOS-GFP attached to cytoplasmic ribosomes (see Fig. 8). These data
are in agreement with fractionation studies that show a
majority of eNOS in EC (90-95%) tightly associated with
intracellular membranes, with the remaining being cytosolic (5-10%; Forstermann et al., 1991
; Pollock et al., 1991
; Liu
et al., 1995
). To confirm the identical perinuclear localization of the eNOS-GFP construct to that of nontagged eNOS,
NIH 3T3 cells were transfected with eNOS-GFP or WT
eNOS, and the proteins were colocalized with the resident
intraluminal Golgi protein Man II in fixed cells. Previous
data demonstrated that GFP fluorescence was preserved
in fixed cells (Chalfie et al., 1994
). As seen in Fig. 1 B,
eNOS-GFP colocalized with Man II in exactly the same
pattern as seen in cells transfected with the WT eNOS cDNA
(Fig. 1 C). In some cells, GFP fluorescence also occurred
in discrete regions of the plasma membrane, consistent with previous reports that a fraction of eNOS resides in plasmalemmal caveolae and interacts with caveolin-1 (García-Cardeña et al., 1996a
,b). Therefore, tagging of eNOS with
GFP does not alter its intracellular localization.
Fig. 1.
eNOS-GFP has the same intracellular localization as WT eNOS
and colocalizes with Man II. NIH 3T3
cells transfected with GFP, WT eNOS-
GFP, or WT eNOS were visualized in
live cells by fluorescence microscopy
(A), or colocalized with a Golgi
marker, Man II, in fixed cells (B and
C). IF, immunofluorescence.
[View Larger Version of this Image (37K GIF file)]
Fig. 8.
Inhibition of eNOS palmitoylation does not alter its
overall membrane association. NIH 3T3 cells were transfected with
WT, C15/26S, L2S, C/L2S, or G2A eNOS-GFP constructs, and
lysates were separated into cytosolic (C) and membrane (M) and
fractions. The GFP proteins were immunoprecipitated with a
GFP polyclonal antibody and analyzed by Western blotting with
an eNOS mAb.
[View Larger Version of this Image (29K GIF file)]
Fig. 3.
Targeting of deletion
mutants of eNOS-GFP. (A)
NIH 3T3 cells were transfected
with WT eNOS-GFP or truncated eNOS-GFP constructs, and GFP fluorescence was visualized in live cells by fluorescence microscopy. (B) Fatty acylation of immunoprecipitated
eNOS (1-35) GFP and WT
eNOS-GFP constructs and relative partitioning of the 1-35 construct between cytosol (C) and
membrane (M) fractions (compared to a soluble G2A eNOS
[1-73] GFP construct) were determined.
[View Larger Version of this Image (46K GIF file)]
Fig. 4.
The first 35 amino
acids of eNOS constitute a
Golgi-targeting signal. (A)
eNOS (1-35/74-131) GFP
was visualized in live cells (left panel) or colocalized with
Man II in fixed cells (center and right panels). (B) eNOS
(1-35) G10-GFP was visualized in live cells (left panel) or
colocalized with Man II in
fixed cells (center and right
panels). (C) eNOS (1-35/74-
131) GFP and eNOS (1-35) G10-GFP are myristoylated
and palmitoylated. NIH 3T3
cells transfected with GFP
or eNOS-GFP constructs
were labeled with [3H]myristic acid or [3H]palmitic acid.
The GFP proteins were immunoprecipitated with GFP
antibodies and analyzed by
fluorography. The bands are
appropriate sizes from the
coding regions.
[View Larger Version of this Image (32K GIF file)]
). For the palmitoylation-deficient protein, only a small fraction of the
GFP fusion colocalized with the Golgi marker. Labeling of
C15/26S eNOS-GFP-transfected cells with an antibody to
calnexin, a resident glycoprotein chaperone of the ER, resulted in an immunofluorescent pattern distinct from the
GFP fluorescence (data not shown). Therefore, N-myristoylation and cysteine palmitoylation are critical determinants of Golgi targeting and/or retention.
Fig. 5.
Lipid modifications influence the subcellular targeting
of eNOS-GFP constructs. NIH 3T3 cells were transfected with G2A
eNOS-GFP (nonacylated, A) or C15/26S eNOS-GFP (myristoylated but not palmitoylated, B) constructs, and were colocalized
in fixed cells with the resident Golgi protein Man II.
[View Larger Version of this Image (45K GIF file)]
; Robinson
and Michel, 1995
; García-Cardeña et al., 1996a
). To see if
this repeat influences eNOS fatty acylation and localization, we mutated the five leucine residues to serine in the
context of WT eNOS-GFP (named L2S eNOS-GFP) or in
the context of the palmitoylation mutant C15/26S eNOS-
GFP (named C/L2S eNOS-GFP), respectively (see Fig. 2 B).
Transfection of these constructs followed by metabolic labeling with the appropriate 3H-fatty acid showed that mutation of the leucine residues did not influence N-myristoylation but abolished palmitoylation (Fig. 6). Similar
amounts of eNOS protein were present in all lanes, as determined by Coomassie blue staining of the gels, before
autoradiography (data not shown). Analysis of the cellular
localization of these constructs demonstrated that L2S and
C/L2S eNOS-GFP were mislocalized (Fig. 7) in a fashion
similar to the palmitoylation mutant C15/26S eNOS-GFP
(see Fig. 5 B), with only a small fraction of the palmitoylation-deficient proteins colocalizing with Man II and the
rest associated with other intracellular organelles.
Fig. 6.
Mutation of the leucines between the palmitoylation
sites abolishes eNOS palmitoylation. NIH 3T3 cells were transfected with eNOS-GFP constructs, and the cells were labeled with
[3H]myristic acid or [3H]palmitic acid. The GFP proteins were
immunoprecipitated with GFP antibodies and analyzed by fluorography.
[View Larger Version of this Image (43K GIF file)]
Fig. 7.
The glycine-leucine repeat is necessary for eNOS intracellular localization. NIH 3T3 cells were transfected with L2S or
C/L2S eNOS-GFP constructs, and proteins were colocalized with
Man II. Note that the L2S and C/L2S proteins appear to be mislocalized in a similar manner, suggesting that palmitoylation is required for proper Golgi localization.
[View Larger Version of this Image (58K GIF file)]
Discussion
; Liu et al., 1996
). Thus, the present study was undertaken to better understand the sequences and modifications required for targeting this peripheral membrane protein to
the Golgi region of EC. We demonstrate that GFP-tagged
eNOS is a useful tool to examine the localization of the
wild-type protein in living and fixed cells. The first 35 amino acids of eNOS, including the N-myristoylation and
cysteine palmitoylation sites, target the fusion partner into
the Golgi region of NIH 3T3 cells. Abolition of fatty acylation in the context of the G2A mutant prevents the colocalization of eNOS with the resident Golgi protein Man II, whereas mutation of the palmitoylation sites or the leucines embedded in the pentameric glycine-leucine repeat
flanking the palmitoylation sites reveals a more diffuse
perinuclear localization of the enzyme. Thus, our data
demonstrate for the first time that fatty acylation is important for Golgi targeting and/or retention, and suggest a
model for the subcellular trafficking of other dually acylated proteins that localize in both the Golgi and plasma
membrane microdomains, including G protein
subunits.
; Robbins et al., 1995
). Moreover, using
both silica purification of caveolae from intact lung endothelium and detergent-free purification of caveolae from cultured cells, the majority of immunoreactive eNOS in
the plasma membrane is in the caveolae (García-Cardeña
et al., 1996a
; Shaul et al., 1996
). Based on confocal microscopy of eNOS in cultured EC and isolation of plasma
membranes and caveolae from intact lung and EC in culture, ~10-50% of eNOS resides in caveolae at a given
point in time (García-Cardeña et al., 1996a
). In the present
study, the eNOS-GFP fluorescence pattern in living or fixed cells confirms eNOS in both Golgi and plasma membrane domains. However, we should point out that all cells
transfected with WT eNOS-GFP show the protein in the
Golgi region, whereas only a small number of cells (~5-10%) show GFP fluorescence readily detectable in the
plasma membrane at cell borders. This difference may result from the nature of transient transfections, the timing
of microscopic evaluation of the cells after transfection,
the dynamic nature of protein trafficking, or the inability
to visualize cell surface-associated eNOS. Additionally, regulation of eNOS trafficking in and out of the plasma membrane is likely different in NIH 3T3 cells and EC, because
a majority (80%) of microvascular EC show eNOS-GFP in both the Golgi and plasmalemmal domains (Liu, J., T.E.
Hughes, and W.C. Sessa, unpublished observations). A
priori, it seems logical that the partitioning of eNOS into
the caveolae is a more complicated event that likely requires additional modifications such as phosphorylation or
regulated protein-protein interactions for anterograde
trafficking from Golgi to caveolae or vice versa. This is
supported by demonstrations that eNOS is modified by
serine and tyrosine phosphorylation (Michel et al., 1993
;
García-Cardeña et al., 1996b
), interacts with caveolin-1 and
other proteins (García-Cardeña et al., 1996b
; Feron et al.,
1996
; Venema et al., 1996
), and that cholesterol-binding
drugs, hormones, protein phosphatase inhibitors, microtubule-disrupting agents, and GTP hydrolysis all influence the dynamic nature of caveolae and/or the distribution of
caveolin-1 (Murata et al., 1995
; Smart et al., 1994a
,b, 1995;
Schnitzer et al., 1994
-1996; Conrad et al., 1995
). Thus, the
eNOS-GFP constructs will be useful reagents to elucidate
the molecular signals required for efficient Golgi-to-caveolae shuttling in EC.
). However, we cannot rule out the
possibility based on the membrane association of the
myristoylated eNOS (1-35) GFP fusion protein, where
ionic, hydrophobic, and other interactions between the
protein and membrane are likely to occur in vivo to enhance the interaction of NH2-terminal myristate with biological membranes. In the full-length construct, mutation
of the N-myristoylation site inhibits palmitoylation and
randomly distributes eNOS into the cytosol, whereas mutation of the palmitoylation sites or replacement of glycine
with serine in the pentameric glycine-leucine repeat does
not affect N-myristoylation and membrane association, but
results in the distribution of eNOS to other intracellular
membranes other than Golgi. At the present time, we do
not know the precise intracellular targeting of the palmitoylation mutants. Because different mutations, all which block palmitoylation but not N-myristoylation, result in
similar focal fluorescence patterns, it is possible that nonpalmitoylated eNOS cannot stably interact with proteins
or lipids of Golgi or plasma membranes, and that it mislocalizes to another membrane compartment, perhaps the
ER or ERGIC.
subunits and Src family members (Shenoy-Scaria et al., 1994
;
Gauen et al., 1996
). G protein
subunits localize in distinct
Golgi compartments (Stow et al., 1991
; Denker et al., 1996
)
and in plasma membrane caveolae in epithelial cells, transfected COS cells, and EC (Chun et al., 1994
; Schnitzer et al.,
1995
). However, the Src family of kinases appears to have
cell-specific localization patterns. For example, Lck and
Fyn tyrosine kinases are N-myristoylated and cysteine palmitoylated, but have distinct intracellular localizations
in human T lymphocytes (Ley et al., 1994
). In T lymphoblasts, Lck was detected at the plasma membrane, while
Fyn localized with centrosomal and microtubule bundles
radiating from the centrosome in interphase cells or with
mitotic spindle and poles in mitotic cells, but was not detected at the plasma membrane. More recently, Fyn was
localized in the plasma membrane of transfected HeLa
cells. Mutation of lysines 7 and 9 of Fyn (K7/9A Fyn) did
not influence N-myristoylation or cysteine palmitoylation,
but changed its typical plasma membrane pattern into a
cytoplasmic and nuclear localization (Gauen et al., 1996
).
In 3T3 cells, Fyn is cotranslationally N-myristoylated on
cytoplasmic ribosomes, and is rapidly targeted to the plasma membrane, where it can be palmitoylated (van't Hof and
Resh, 1997). In addition, the aquisition of palmitate precedes its apparent localization to Triton-insoluble membranes. Using immunofluorescence microscopy techniques,
however, Fyn is localized in the perinuclear membranes
and plasmalemma of 3T3 cells and COS cells, similar to
eNOS in 3T3 cells and EC (Sessa et al., 1995
; Garcia-Cardena et al., 1996a; van't Hof and Resh, 1997). Therefore, it is possible that myristoyl-eNOS initially targets to
the plasma membrane, where it can be palmitoylated by a
plasma membrane cysteine palmitoyl transferase (Dunphy
et al., 1996
) and partition into caveolae. If so, then eNOS
on the Golgi reflects accumulation from the fission and
retrograde transport of caveolae (Schnitzer et al., 1996
). Also, if this is true, then the rate of fission and retrograde transport of eNOS far exceeds that of plasma membrane
targeting, palmitoylation, and entrance into caveolae. An
alternative but not exclusive model is that eNOS is cotranslationally N-myristoylated on a cytoplasmic ribosome
(Liu and Sessa, 1994
) and targets onto the cytoplasmic
face of the Golgi via lipid-lipid or lipid-protein interactions, possibly through an unidentified myristoyl protein chaperone, where it is kinetically trapped on Golgi membranes by subsequent palmitoylation (Schmidt and Catterall, 1987
; Gutierrez and Magee, 1991
). Palmitoylation, per
se, does not contribute to overall hydrophobicity or stable
membrane association (Liu et al., 1996
), but it significantly
contributes to proper subcellular targeting, perhaps by facilitating protein-protein or lipid-protein interactions with
caveolin-1 (García-Cardeña et al., 1996b
). Once in the
Golgi region, eNOS has the capacity to move to detergent-insoluble domains and caveolae of the plasma membrane
because palmitoylation mutants of eNOS do not target to
plasmalemmal caveolae and reside in a diffuse perinuclear
pattern (García-Cardeña et al., 1996a
; Shaul et al., 1996
and this study). In both situations with Fyn and eNOS, it is
clear that fatty acylation orients the amino terminus so
that ionic interactions between the acylated protein and
target lipids and/or proteins can occur.
; Resh, 1994
), was speculated to be important for its membrane association and
targeting (Liu et al., 1995
). Changing the hydrophobic leucines to serines in the pentameric glycine-leucine repeat
attenuates palmitoylation and results in a more diffuse perinuclear pattern of fluorescence. Similar data were observed with any palmitoylation mutant in the context of full-length or truncated GFP constructs (palmitoylation mutants
of eNOS [1-73] GFP and [1-131] GFP, data not shown).
This suggests that the intervening sequences between two
palmitoylation sites (cysteines 15 and 26) will influence
recognition by cysteine palmitoyl transferases without influencing other modifications such as N-myristoylation or
dimer assembly (assayed indirectly by activity measurements). Palmitoylation appears to be necessary for targeting eNOS and certain Src family members to caveolae
(García-Cardeña et al., 1996a
; Shaul et al., 1996
; Shenoy-Scaria et al., 1994
). The molecular mechanism for this is
not known, but is likely ascribed to its involvement in protein-protein and/or protein-lipid interactions. Palmitoylation of Fyn tyrosine kinase has been shown to participate in its interaction with T cell antigen receptor (Gauen et al., 1996
). The lipid composition of different membrane compartments are distinct, with higher cellular cholesterol content found in the Golgi and plasma membrane microdomains, including caveolae. Thus, palmitate may enhance
and stabilize the binding of eNOS to caveolin, a cholesterol-binding protein (Murata et al., 1995
), other Golgi
targets, or specific membrane components. The loss of
palmitate on eNOS incurred by site-directed mutagenesis
of cysteines 15 and 26 or by mutation of the sequences between the palmitoylation sites may dampen its ability to
interact with specific proteins and lipids on Golgi and/or
caveolae membranes, resulting in a membrane protein
properly targeted but no longer confined to the Golgi. A
similar mechanism of membrane tethering was recently proposed for dually acylated G proteins
subunits found
in Golgi and plasma membrane (Denker et al., 1996
). However, palmitoylation, per se, is not sufficient for Golgi targeting of another peripheral membrane protein, GAD65.
GAD65 targets into the Golgi of pancreatic
cells or
transfected CHO cells, and mutation of the palmitoylation sites inhibits palmitoylation but does not influence Golgi
targeting or stable membrane association (Shi et al., 1994
;
Solimena et al., 1994
). Thus, for the targeting of dually acylated proteins, myristate in the context of nearby amino
acids confers their ability to target and to be palmitoylated, and in turn, the palmitate helps the proteins to their
final destinations to interact with specific effectors.
Footnotes
Please address all correspondence to William C. Sessa, Boyer Center for
Molecular Medicine, Room 436D, Yale University School of Medicine,
295 Congress Avenue, New Haven, CT 06536-0812. Tel.: (203) 737-2291. Fax: (203) 737-2290.
References
1.
Bredt, D.S., and
S.H. Snyder.
1990.
Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.
Proc. Natl. Acad. Sci. USA.
87:
682-685
[Abstract].
2.
Chalfie, M.,
Y. Tu,
G. Euskirchen,
W.W. Ward, and
D.C. Prasher.
1994.
Green
fluorescent protein as a marker for gene expression.
Science (Wash. DC).
263:
802-805
3.
Chun, M.,
U.K. Liyanage,
M.P. Lisanti, and
H.F. Lodish.
1994.
Signal transduction
of a G protein-coupled receptor in caveolae: colocalization of endothelin
and its receptor with caveolin.
Proc. Natl. Acad. Sci. USA.
91:
11728-11732
4.
Conrad, P.A.,
E.J. Smart,
Y. Ying,
R.G.W. Anderson, and
G.S. Bloom.
1995.
Caveolin cycles between plasma membrane caveolae and the Golgi complex
by microtubule-dependent and microtubule-independent steps.
J. Cell Biol.
131:
1421-1433
[Abstract].
5.
Denker, S.P.,
J.M. McCaffery,
G.E. Palade,
P.A. Insel, and
M.G. Farquhar.
1996.
Differential distribution of subunits and
subunits of heterotrimeric G proteins on Golgi membranes of the exocrine pancreas.
J. Cell Biol.
133:
1027-1040
[Abstract].
6.
Dunphy, J.T.,
W.K. Greentree,
C.L. Manahan, and
M.E. Linder.
1996.
G-protein palmitoyltransferase activity is enriched in plasma membranes.
J. Biol.
Chem.
271:
7154-7159
7.
Feron, O.,
L. Belhassen,
L. Kobzik,
T.W. Smith,
R.A. Kelly, and
T. Michel.
1996.
Endothelial nitric oxide synthase targeting to caveolae.
J. Biol. Chem.
271:
22810-22814
8.
Forstermann, U.,
J.S. Pollock,
H.H.H.W. Schmidt,
M. Heller, and
F. Murad.
1991.
Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide
synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.
Proc. Natl. Acad. Sci. USA.
88:
1788-1792
[Abstract].
9.
García-Cardeña, G.,
P. Oh,
J. Liu,
J.E. Schnitzer, and
W.C. Sessa.
1996a.
Targeting of nitric oxide synthase to endothelial caveolae via palmitoylation.
Proc. Natl. Acad. Sci. USA.
93:
6448-6453
10.
García-Cardeña, G.,
R. Fan,
D.F. Stern,
J. Liu, and
W.C. Sessa.
1996b.
Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1.
J. Biol. Chem.
271:
27237-27240
11.
Gauen, L.K.T.,
M.E. Linder, and
A.S. Shaw.
1996.
Multiple features of the
p59fyn src homology 4 domain define a motif for immune receptor-based activation motif (ITAM) binding and for plasma membrane localization.
J.
Cell Biol.
133:
1007-1015
[Abstract].
12.
Gutierrez, L., and
A.I. Magee.
1991.
Characterization of an acyltransferase acting
on p21N-ras protein in a cell-free system.
Biochem. Biophys. Acta.
1078:
147-154
13.
Htun, H.,
J. Barsony,
I. Renyi,
D.L. Gould, and
G.L. Hager.
1996.
Visualization
of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera.
Proc. Natl. Acad. Sci. USA.
93:
4845-4850
14.
Kantor, D.B.,
M. Lanzrein,
S.J. Stary,
G.M. Sandoval,
W.B. Smith,
B.M. Sullivan,
N. Davidson, and
E.M. Schuman.
1996.
A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue.
Science (Wash. DC).
274:
1744-1748
15.
Ley, S.C.,
M. Marsh,
C.R. Bebbington,
K. Proudfoot, and
P. Jordan.
1994.
Distinct intracellular localization of Lck and Fyn protein tyrosine kinases in human T lymphocytes.
J. Cell Biol.
125:
639-649
[Abstract].
16.
Liu, J., and
W.C. Sessa.
1994.
Identification of covalently bound amino-terminal
myristic acid in endothelial nitric oxide synthase.
J. Biol. Chem.
269:
11691-11694
17.
Liu, J.,
G. García-Cardeña, and
W.C. Sessa.
1995.
Biosynthesis and palmitoylation of endothelial nitric oxide synthase: mutagenesis of palmitoylation sites,
cysteine 15 and/or 26, argue against depalmitoylation induced translocation
of the enzyme.
Biochemistry.
34:
12333-12340
18.
Liu, J.,
G. García-Cardeña, and
W.C. Sessa.
1996.
Palmitoylation of endothelial
nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization.
Biochemistry.
35:
13277-13281
19.
Marshall, J.,
M. Raymond,
G.W.J. Moss,
J.R. Howe, and
T.E. Hughes.
1995.
The jellyfish green fluorescent protein: a new tool for studying ion channel
expression and function.
Neuron.
14:
211-215
20.
Michel, T.,
G.K. Li, and
L. Busconi.
1993.
Phosphorylation and subcellular
translocation of endothelial nitric oxide synthase.
Proc. Natl. Acad. Sci.
USA.
90:
6252-6256
[Abstract].
21.
Moreman, K.W., and
O. Touster.
1986.
Topology of mannosidase II in rat liver
Golgi membranes and release of the catalytic domain by selective proteolysis.
J. Biol. Chem.
261:
10945-10951
22.
Moriyoshi, K.,
L.J. Richards,
C. Akazawa,
D.D.M. O'Leary, and
S. Nakanishi.
1996.
Labeling neural cells using adenoviral gene transfer of membrane targeted GFP.
Neuron.
16:
255-260
23.
Mumby, S.M.,
C. Kleuss, and
A.G. Gilman.
1994.
Receptor regulation of
G-protein palmitoylation.
Proc. Natl. Acad. Sci. USA.
91:
2800-2804
[Abstract].
24.
Murata, M.,
J. Peranen,
R. Schreiner,
F. Wieland,
T.V. Kurzchalia, and
K. Simons.
1995.
VIP21/caveolin is a cholesterol-binding protein.
Proc. Natl. Acad.
Sci. USA.
92:
10339-10343
[Abstract].
25.
Peitzsch, R.M., and
S. McLaughlin.
1993.
Binding of acylated peptides and fatty
acids to phospholipid vesicles: pertinence to myristoylated proteins.
Biochemistry.
32:
10436-10443
26.
Pollock, J.S.,
U. Forstermann,
J.A. Mitchell,
T.D. Warner,
H.H.H.W. Schmidt,
M. Nakane, and
F. Murad.
1991.
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native
bovine aortic endothelial cells.
Proc. Natl. Acad. Sci. USA.
88:
10480-10484
[Abstract].
27.
Prasher, D.C.,
V.K. Eckenrode,
W.W. Ward,
F.G. Prendergast, and
M.J. Cormier.
1992.
Primary structure of the Aequorea victoria green-fluorescent protein.
Gene (Amst.).
111:
229-233
28.
Resh, M.D..
1994.
Myristoylation and palmitoylation of Src family members: the
fats of the matter.
Cell.
76:
411-413
29.
Robbins, S.M.,
N.A. Quintrell, and
J.M. Bishop.
1995.
Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and association with caveolae.
Mol. Cell. Biol.
15:
3507-3515
[Abstract].
30.
Robinson, L.J., and
T. Michel.
1995.
Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and
subcellular targeting.
Proc. Natl. Acad. Sci. USA.
92:
11776-11780
[Abstract].
31.
Schmidt, J.W., and
W.A. Catterall.
1987.
Palmitoylation, sulfation, and glycosylation of the alpha subunit of the sodium channel. Role of post-translational
modifications in channel assembly.
J. Biol. Chem.
262:
13713-13723
32.
Schnitzer, J.E.,
P. Oh,
E. Pinney, and
J. Allard.
1994.
Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules.
J. Cell Biol.
127:
1217-1232
[Abstract].
33.
Schnitzer, J.E.,
J. Liu, and
P. Oh.
1995.
Endothelial caveolae have the molecular
transport machinery for vesicle budding, docking, and fusion including
VAMP, NSF, SNAP, annexin, and GTPases.
J. Biol. Chem.
270:
14399-14404
34.
Schnitzer, J.E.,
P. Oh, and
D.P. McIntosh.
1996.
Role of GTP hydrolysis in fission
of caveolae directly from plasma membranes.
Science (Wash. DC).
274:
239-242
35.
Sessa, W.C.,
C.M. Barber, and
K.R. Lynch.
1993.
Mutation of N-myristoylation
site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein.
Circ. Res.
72:
921-924
[Abstract].
36.
Sessa, W.C.,
G. García-Cardeña,
J. Liu,
A. Keh,
J.S. Pollock,
J. Bradley,
S. Thiru,
I.M. Braverman, and
K.M. Desai.
1995.
The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric
oxide.
J. Biol. Chem.
270:
17641-17644
37.
Shaul, P.W.,
E.J. Smart,
L.J. Robinson,
Z. German,
I.S. Yuhanna,
Y. Ying,
R.G.W. Anderson, and
T. Michel.
1996.
Acylation targets endothelia nitric-oxide synthase to plasmalemmal caveolae.
J. Biol. Chem.
271:
6518-6522
38.
Shenoy-Scaria, A.M.,
D.J. Dietzen,
J. Kwong,
D.C. Link, and
D.M. Lublin.
1994.
Cysteine 3 of Src family protein tyrosine kinase determines palmitoylation and localization in caveolae.
J. Cell Biol.
126:
353-363
[Abstract].
39.
Shi, Y.,
B. Veit, and
S. Baekkeskov.
1994.
Amino acid residues 24-31 but not
palmitoylation of cysteines 30 and 45 are required for membrane anchoring
of glutamic acid decarboxylase, GAD65.
J. Cell Biol.
124:
927-934
[Abstract].
40.
Smart, E.J.,
Y. Ying,
P.A. Conrad, and
R.G.W. Anderson.
1994a.
Caveolin
moves from caveolae to the Golgi apparatus in response to cholesterol oxidation.
J. Cell Biol.
127:
1185-1197
[Abstract].
41.
Smart, E.J.,
D.C. Foster,
Y. Ying,
B.A. Kamen, and
R.G.W. Anderson.
1994b.
Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae.
J. Cell Biol.
124:
307-313
[Abstract].
42.
Smart, E.J.,
Y. Ying, and
R.G.W. Anderson.
1995.
Hormonal regulation of caveolae internalization.
J. Cell Biol.
131:
929-938
[Abstract].
43.
Solimena, M.,
R. Dirkx Jr.,
M. Radzynski,
O. Mundigl, and
P. De Camilli.
1994.
A signal located within amino acids 1-27 of GAD65 is required for its targeting to the Golgi complex region.
J. Cell Biol.
126:
331-341
[Abstract].
44.
Stauber, R.,
G.A. Gaitanaris, and
G.N. Pavlakis.
1995.
Analysis of trafficking of
Rev and transdominant Rev proteins in living cells using green fluorescent
protein fusions: transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm.
Virology.
213:
439-449
45.
Stow, J.L.,
J.B. de Almeida,
E.J. Narula,
E.J. Holtzman,
L. Ercolani, and
D.A. Ausiello.
1991.
A heterotrimeric G protein, G i-3, on Golgi membranes regulates the secretion of a heparan sulfate proteoglycan in LLC-PK1 epithelial
cells.
J. Cell Biol.
114:
1113-1124
[Abstract].
46.
van't Hof, W., and
M.D. Resh.
1997.
Rapid plasma membrane anchoring of
newly synthesized p59fyn: selective requirement for NH2-terminal myristoylation and palmitoylation at cysteine-3.
J. Cell Biol.
136:
1023-1035
47.
Venema, V.J.,
M.B. Marrero, and
R.C. Venema.
1996.
Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton.
Biochem. Biophys. Res. Commun.
226:
703-710
48.
Wedegaertner, P.B.,
P.T. Wilson, and
H.R. Bourne.
1995.
Lipid modifications
of trimeric G proteins.
J. Biol. Chem.
270:
503-506
Copyright © 1997
by The Rockefeller University Press.